Clinical Trials

Temple University School of Podiatric Medicine Journal Review Club
Editor's note: This post is part of the Temple University School of Podiatric Medicine (TUSPM) journal review club blog series. In each blog post, a TUSPM student will review a journal article relevant to wound management and related topics and provide their evaluation of the clinical research therein.

Article Title: Stem Cells Derived from Burned Skin – The Future of Burn Care
Authors: Saeid Amini-Nik; Reinhard Dolp; Gertraud Eylert; Andrea-Kaye Datu; Alexandra Parousis; Camille Blakeley; Marc G. Jeschke (Sunnybrook Research Institute, Canada)
Journal: EBioMedicine
Reviewed by: Akhil Korrapati, Temple University School of Podiatric Medicine Class of 2021, Temple University School of Podiatric Medicine

by Ivy Razmus, RN, PhD, CWOCN

As we continually focus on improving our skills in prevention and management of skin and wounds, we are beginning to understand that one size does not fit all; or, in other words, prevention and management in wound care are dependent on the size and age of the patient. In wound care, one method of care does not fit all types of patients. Although those clinicians who work with younger populations know this to be true based on our personal experience, this can be a problem if the purchasing of products for younger patients' skin and wound care is decided without the input of the providers and caregivers who care for them.

by Thomas E. Serena, MD, FACS, FACHM, FAPWCA

by Margaret Heale RN, MSc, CWOCN

The research lecturer's name was Terry, and he had my respect and attention. Many of the students were dreading the research modules but were cheered by the prospect of Terry taking us through it.

By Thomas E. Serena MD, FACS, FACHM, FAPWCA

Editor's note:This blog post is part of the WoundSource Trending Topics series, bringing you insight into the latest clinical issues and advancement in wound management, with contributions by the WoundSource Editorial Advisory Board.

Temple University School of Podiatric Medicine Journal Review Club
Editor's note: This post is part of the Temple University School of Podiatric Medicine (TUSPM) journal review club blog series. In each blog post, a TUSPM student will review a journal article relevant to wound management and related topics and provide their evaluation of the clinical research therein.

Temple University School of Podiatric Medicine Journal Review Club
Editor's note: This post is part of the Temple University School of Podiatric Medicine (TUSPM) journal review club blog series. In each blog post, a TUSPM student will review a journal article relevant to wound management and related topics and provide their evaluation of the clinical research therein.

Marietta, GA – October 11, 2017 – MiMedx Group, Inc. (NASDAQ: MDXG), a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare, announced today that the latest peer-reviewed clinical study of MiMedx dehydrated human amnion/chorion membrane ("dHACM") allografts has been published in the International Wound Journal.

By Thomas E. Serena MD, FACS, FACHM, FAPWCA

A recent article by Kaiser Health News misquoted me as saying that we enroll only "healthy" patients in our clinical trials. At moments like this, one feels that something has been overlooked. One of my research coordinators, recalling the serious adverse events (SAEs) of the previous week said, "The only patients sicker than ours are underground."

By the WoundSource Editors

Canton, MA – March 27, 2017 – Organogenesis Inc., a global leader in advanced wound care innovations and technologies, today announced the launch of a PuraPly™ Antimicrobial (PuraPly™ AM) clinical research program which will comprise multiple studies and a nationwide patient registry.